Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 377

1.

Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma.

Travis LB, Curtis RE, Glimelius B, Holowaty EJ, Van Leeuwen FE, Lynch CF, Hagenbeek A, Stovall M, Banks PM, Adami J, et al.

J Natl Cancer Inst. 1995 Apr 5;87(7):524-30.

PMID:
7707439
2.

Risk of leukemia following treatment for non-Hodgkin's lymphoma.

Travis LB, Curtis RE, Stovall M, Holowaty EJ, van Leeuwen FE, Glimelius B, Lynch CF, Hagenbeek A, Li CY, Banks PM, et al.

J Natl Cancer Inst. 1994 Oct 5;86(19):1450-7.

PMID:
8089863
3.

Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.

van Leeuwen FE, Klokman WJ, Stovall M, Hagenbeek A, van den Belt-Dusebout AW, Noyon R, Boice JD Jr, Burgers JM, Somers R.

J Natl Cancer Inst. 1995 Oct 18;87(20):1530-7.

PMID:
7563187
4.

Second cancers among long-term survivors of non-Hodgkin's lymphoma.

Travis LB, Curtis RE, Glimelius B, Holowaty E, Van Leeuwen FE, Lynch CF, Adami J, Gospodarowicz M, Wacholder S, Inskip P, et al.

J Natl Cancer Inst. 1993 Dec 1;85(23):1932-7.

PMID:
8230284
5.

Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study.

Moser EC, Noordijk EM, van Leeuwen FE, Baars JW, Thomas J, Carde P, Meerwaldt JH, van Glabbeke M, Kluin-Nelemans HC.

Haematologica. 2006 Nov;91(11):1481-8.

6.

[Late toxicity after chemotherapy of malignant testicular tumors].

Jakob A, Kollmannsberger C, Kanz L, Bokemeyer C.

Urologe A. 1998 Nov;37(6):635-47. Review. German.

PMID:
9887493
7.

Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease.

Travis LB, Gospodarowicz M, Curtis RE, Clarke EA, Andersson M, Glimelius B, Joensuu T, Lynch CF, van Leeuwen FE, Holowaty E, Storm H, Glimelius I, Pukkala E, Stovall M, Fraumeni JF Jr, Boice JD Jr, Gilbert E.

J Natl Cancer Inst. 2002 Feb 6;94(3):182-92.

PMID:
11830608
8.

Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.

Mauch PM, Kalish LA, Marcus KC, Coleman CN, Shulman LN, Krill E, Come S, Silver B, Canellos GP, Tarbell NJ.

Blood. 1996 May 1;87(9):3625-32.

9.

Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.

Knight A, Askling J, Granath F, Sparen P, Ekbom A.

Ann Rheum Dis. 2004 Oct;63(10):1307-11. Review.

10.

Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.

van Leeuwen FE, Klokman WJ, Stovall M, Dahler EC, van't Veer MB, Noordijk EM, Crommelin MA, Aleman BM, Broeks A, Gospodarowicz M, Travis LB, Russell NS.

J Natl Cancer Inst. 2003 Jul 2;95(13):971-80.

PMID:
12837833
11.

Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.

van den Belt-Dusebout AW, Aleman BM, Besseling G, de Bruin ML, Hauptmann M, van 't Veer MB, de Wit R, Ribot JG, Noordijk EM, Kerst JM, Gietema JA, van Leeuwen FE.

Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1420-9. doi: 10.1016/j.ijrobp.2009.01.073.

PMID:
19931732
12.

Treatment-associated leukemia following testicular cancer.

Travis LB, Andersson M, Gospodarowicz M, van Leeuwen FE, Bergfeldt K, Lynch CF, Curtis RE, Kohler BA, Wiklund T, Storm H, Holowaty E, Hall P, Pukkala E, Sleijfer DT, Clarke EA, Boice JD Jr, Stovall M, Gilbert E.

J Natl Cancer Inst. 2000 Jul 19;92(14):1165-71.

PMID:
10904090
13.

Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.

Sparano JA, Hu X, Wiernik PH, Sarta C, Reddy DM, Hanau L, Henry DH.

J Natl Cancer Inst. 1997 Feb 19;89(4):301-7.

PMID:
9048834
14.

Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.

Bokemeyer C, Schmoll HJ, van Rhee J, Kuczyk M, Schuppert F, Poliwoda H.

Ann Hematol. 1994 Mar;68(3):105-10.

PMID:
8167175
15.

A phase II multicenter trial of high-dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for patients with high-risk non-Hodgkin's lymphoma.

Schenkein DP, Roitman D, Miller KB, Morelli J, Stadtmauer E, Pecora AL, Cassileth P, Fernandez H, Cooper BW, Kutteh L, Lazarus HM.

Biol Blood Marrow Transplant. 1997 Oct;3(4):210-6.

PMID:
9360783
16.

Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma.

Pedersen-Bjergaard J, Ersbøll J, Hansen VL, Sørensen BL, Christoffersen K, Hou-Jensen K, Nissen NI, Knudsen JB, Hansen MM.

N Engl J Med. 1988 Apr 21;318(16):1028-32.

PMID:
3352696
17.

Breast cancer after treatment of Hodgkin's disease.

Hancock SL, Tucker MA, Hoppe RT.

J Natl Cancer Inst. 1993 Jan 6;85(1):25-31.

PMID:
8416252
19.
20.

Supplemental Content

Support Center